Evaluation of active neutrophil elastase in sputum of bronchiectasis and cystic fibrosis patients: A comparison among different techniques-Reference-Cited by-同舟云学术

Evaluation of active neutrophil elastase in sputum of bronchiectasis and cystic fibrosis patients: A comparison among different techniques

Published:2019-12 Issue: Volume:59 Page:101856
ISSN:1094-5539
Container-title:Pulmonary Pharmacology & Therapeutics
language:en
Short-container-title:Pulmonary Pharmacology & Therapeutics

Author:

Oriano Martina,Terranova Leonardo,Sotgiu Giovanni,Saderi Laura,Bellofiore Angela,Retucci Mariangela,Marotta Cinzia,Gramegna Andrea,Miglietta Daniela,Carnini Chiara,Marchisio Paola,Chalmers James D.,Aliberti Stefano,Blasi Francesco

Funder

Chiesi Farmaceutici

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biochemistry (medical),Pulmonary and Respiratory Medicine

Reference13 articles.

1. European Respiratory Society guidelines for the management of adult bronchiectasis;Polverino;Eur. Respir. J.,2017

2. Diagnosis of cystic fibrosis: consensus guidelines from the cystic fibrosis foundation;Farrell;J. Pediatr.,2018

3. Persistent sputum cellularity and neutrophils may predict bronchiectasis;Drost;Can. Respir. J.,2011

4. Human neutrophil peptides and phagocytic deficiency in bronchiectatic lungs;Voglis;Am. J. Respir. Crit. Care Med.,2009

5. Neutrophil-mediated degradation of lung proteoglycans;SHUM;Am. J. Respir. Crit. Care Med.,2000

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Flagellum-deficient Pseudomonas aeruginosa is more virulent than non-motile but flagellated mutants in a cystic fibrosis mouse model;Microbiology Spectrum;2024-09-09

2. A GMR enzymatic assay for quantifying nuclease and peptidase activity;Frontiers in Bioengineering and Biotechnology;2024-03-13

3. Mucus Structure, Viscoelastic Properties, and Composition in Chronic Respiratory Diseases;International Journal of Molecular Sciences;2024-02-05

4. Barriers for orally inhaled therapeutic antibodies;Expert Opinion on Drug Delivery;2023-08-03

5. Microbial Inflammatory Networks in Bronchiectasis Exacerbators With Pseudomonas aeruginosa;CHEST;2023-07